Total Visits

Views
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.34

Total Visits Per Month

September 2020October 2020November 2020December 2020January 2021February 2021March 2021
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer.3030400

File Downloads

Views
222546_1_merged_1568669647.pdf6

Top country views

Views
United States19
United Kingdom9
Germany4
Japan1

Top cities views

Views
Oakland7
Ashburn5
Fairfield4
Osaka1